3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Nivolumab
5
aldesleukin
3
Ipilimumab
3
Blood Specimen Collection
3
relatlimab
2
Vemurafenib
2
Immune Checkpoint Inhibitors
2
trametinib
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
technetium Tc 99m nanocolloid
1
sargramostim
1
pembrolizumab
1
pasireotide
1
encorafenib
1
dabrafenib
1
binimetinib
1
Vindesine
1
Standard of Care
1
Specimen Handling
1
Sevoflurane
1
Propofol
1
Pharmaceutical Preparations
1
Patient-Specific Modeling
1
Isoflurane
1
Interleukins
1
Interleukin-2
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Fibrin Tissue Adhesive
1
Etanercept
1
Desflurane
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Melanoma
×
Patient-Specific Modeling
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn